These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16585013)

  • 41. Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma.
    Terui Y; Mishima Y; Sugimura N; Kojima K; Sakurai T; Mishima Y; Kuniyoshi R; Taniyama A; Yokoyama M; Sakajiri S; Takeuchi K; Watanabe C; Takahashi S; Ito Y; Hatake K
    Clin Cancer Res; 2009 Apr; 15(7):2523-30. PubMed ID: 19276251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells.
    Kim JR; Mathew SO; Mathew PA
    Immunobiology; 2016 Jan; 221(1):31-9. PubMed ID: 26310579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature.
    Scheper MA; Nikitakis NG; Fernandes R; Gocke CD; Ord RA; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Aug; 100(2):198-206. PubMed ID: 16037778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
    Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
    Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmablastic lymphoma: a clinicopathologic correlation.
    Folk GS; Abbondanzo SL; Childers EL; Foss RD
    Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
    Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
    Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.
    Wilkinson ST; Vanpatten KA; Fernandez DR; Brunhoeber P; Garsha KE; Glinsmann-Gibson BJ; Grogan TM; Teruya-Feldstein J; Rimsza LM
    Blood; 2012 Feb; 119(6):1459-67. PubMed ID: 22167754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
    Maestre L; García-García JF; Jiménez S; Reyes-García AI; García-González Á; Montes-Moreno S; Arribas AJ; González-García P; Caleiras E; Banham AH; Piris MÁ; Roncador G
    PLoS One; 2020; 15(2):e0229743. PubMed ID: 32106280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.
    Györy I; Fejér G; Ghosh N; Seto E; Wright KL
    J Immunol; 2003 Mar; 170(6):3125-33. PubMed ID: 12626569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells.
    Ochiai K; Katoh Y; Ikura T; Hoshikawa Y; Noda T; Karasuyama H; Tashiro S; Muto A; Igarashi K
    J Biol Chem; 2006 Dec; 281(50):38226-34. PubMed ID: 17046816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Stages of lymphoid tissue ontogenesis and histogenesis of non-Hodgkin lymphoma].
    Krivolanov IuA
    Vopr Onkol; 2005; 51(4):417-26. PubMed ID: 16308972
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma cell differentiation and multiple myeloma.
    Shapiro-Shelef M; Calame K
    Curr Opin Immunol; 2004 Apr; 16(2):226-34. PubMed ID: 15023417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study.
    Pillai G; Cook N; Turley H; Leek RD; Blasquez C; Pezzella F; Harris AL; Gatter KC
    Histopathology; 2005 Feb; 46(2):209-16. PubMed ID: 15693894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy.
    Duckworth A; Glenn M; Slupsky JR; Packham G; Kalakonda N
    Blood; 2014 May; 123(21):3277-85. PubMed ID: 24637363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas.
    Vrzalikova K; Woodman CB; Murray PG
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):1-6. PubMed ID: 22580854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAX-5 is invariably expressed in B-cell lymphomas without plasma cell differentiation.
    Dong HY; Browne P; Liu Z; Gangi M
    Histopathology; 2008 Sep; 53(3):278-87. PubMed ID: 18643853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.
    Shapiro-Shelef M; Lin KI; McHeyzer-Williams LJ; Liao J; McHeyzer-Williams MG; Calame K
    Immunity; 2003 Oct; 19(4):607-20. PubMed ID: 14563324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.